NESACAINE Drug Patent Profile
Which patents cover Nesacaine, and when can generic versions of Nesacaine launch?
Nesacaine is a drug marketed by Fresenius Kabi Usa and is included in one NDA.
The generic ingredient in NESACAINE is chloroprocaine hydrochloride. There is one drug master file entry for this compound. Five suppliers are listed for this compound. Additional details are available on the chloroprocaine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Nesacaine
A generic version of NESACAINE was approved as chloroprocaine hydrochloride by HIKMA on September 9th, 1998.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for NESACAINE?
- What are the global sales for NESACAINE?
- What is Average Wholesale Price for NESACAINE?
Summary for NESACAINE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 33 |
| Clinical Trials: | 6 |
| Patent Applications: | 4,618 |
| Drug Prices: | Drug price information for NESACAINE |
| What excipients (inactive ingredients) are in NESACAINE? | NESACAINE excipients list |
| DailyMed Link: | NESACAINE at DailyMed |
Recent Clinical Trials for NESACAINE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Johns Hopkins University | Phase 3 |
| Oregon Health and Science University | Early Phase 1 |
| University of Arkansas | Phase 4 |
Pharmacology for NESACAINE
| Drug Class | Ester Local Anesthetic |
| Physiological Effect | Local Anesthesia |
US Patents and Regulatory Information for NESACAINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fresenius Kabi Usa | NESACAINE | chloroprocaine hydrochloride | INJECTABLE;INJECTION | 009435-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Fresenius Kabi Usa | NESACAINE-MPF | chloroprocaine hydrochloride | INJECTABLE;INJECTION | 009435-006 | May 2, 1996 | AP | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Fresenius Kabi Usa | NESACAINE | chloroprocaine hydrochloride | INJECTABLE;INJECTION | 009435-002 | Approved Prior to Jan 1, 1982 | AP | RX | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Fresenius Kabi Usa | NESACAINE-MPF | chloroprocaine hydrochloride | INJECTABLE;INJECTION | 009435-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Fresenius Kabi Usa | NESACAINE-MPF | chloroprocaine hydrochloride | INJECTABLE;INJECTION | 009435-007 | May 2, 1996 | AP | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Fresenius Kabi Usa | NESACAINE-MPF | chloroprocaine hydrochloride | INJECTABLE;INJECTION | 009435-004 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
